Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

284 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Feasibility, tolerability, and safety of hysterosalpingo-foam sonography (hyfosy). multicenter, prospective Spanish study.
Engels V, Medina M, Antolín E, Ros C, Amaro A, De-Guirior C, Manzour N, Sotillo L, De la Cuesta R, Rodríguez R, San-Frutos L, Peralta S, Martin-Martínez A, Alcázar JL. Engels V, et al. Among authors: peralta s. J Gynecol Obstet Hum Reprod. 2021 May;50(5):102004. doi: 10.1016/j.jogoh.2020.102004. Epub 2020 Nov 23. J Gynecol Obstet Hum Reprod. 2021. PMID: 33242678
Age, independent from ovarian reserve status, is the main prognostic factor in natural cycle in vitro fertilization.
González-Foruria I, Peñarrubia J, Borràs A, Manau D, Casals G, Peralta S, Creus M, Ferreri J, Vidal E, Carmona F, Balasch J, Fàbregues F. González-Foruria I, et al. Among authors: peralta s. Fertil Steril. 2016 Aug;106(2):342-347.e2. doi: 10.1016/j.fertnstert.2016.04.007. Epub 2016 Apr 23. Fertil Steril. 2016. PMID: 27117376 Free article.
Comparison between slow freezing and vitrification of ovarian tissue cryopreservation in assigned female at birth transgender people receiving testosterone therapy: data on histological and viability parameters.
Borrás A, Manau D, Fabregues F, Peralta S, Calafell JM, Casals G, Saco A, Agustí I, Carmona F. Borrás A, et al. Among authors: peralta s. J Assist Reprod Genet. 2022 Feb;39(2):527-541. doi: 10.1007/s10815-021-02386-9. Epub 2022 Jan 31. J Assist Reprod Genet. 2022. PMID: 35098405 Free PMC article.
Evaluation of FMR4, FMR5 and FMR6 Expression Levels as Non-Invasive Biomarkers for the Diagnosis of Fragile X-Associated Primary Ovarian Insufficiency (FXPOI).
Alvarez-Mora MI, Agusti I, Wijngaard R, Martinez-Barrios E, Barcos T, Borras A, Peralta S, Guimera M, Goday A, Manau D, Rodriguez-Revenga L. Alvarez-Mora MI, et al. Among authors: peralta s. J Clin Med. 2022 Apr 14;11(8):2186. doi: 10.3390/jcm11082186. J Clin Med. 2022. PMID: 35456280 Free PMC article.
Day-5 inhibin B serum concentrations and antral follicle count as predictors of ovarian response and live birth in assisted reproduction cycles stimulated with gonadotropin after pituitary suppression.
Peñarrubia J, Peralta S, Fábregues F, Carmona F, Casamitjana R, Balasch J. Peñarrubia J, et al. Among authors: peralta s. Fertil Steril. 2010 Dec;94(7):2590-5. doi: 10.1016/j.fertnstert.2010.03.009. Epub 2010 Apr 18. Fertil Steril. 2010. PMID: 20400077 Free article. Clinical Trial.
Spanish post-menopausal women's viewpoints on hormone therapy.
Castelo-Branco C, Ferrer J, Palacios S, Cornago S, Peralta S. Castelo-Branco C, et al. Among authors: peralta s. Maturitas. 2007 Apr 20;56(4):420-8. doi: 10.1016/j.maturitas.2006.11.006. Epub 2006 Dec 14. Maturitas. 2007. PMID: 17174045
284 results